It has been demonstrated that Acyl-CoA synthetase 4 (ACSL4) enzyme expression is elevated in cancer cells, which promotes an aggressive phenotype associated with the dysregulated production of eicosanoids, particularly in breast, colon, hepatocellular and prostate cancer1–8. The gene discussed is ACSL4; the disease is cancer.